International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.7927646
Original Article
Anaesthetic Management of a Patient with Ischemic Heart Disease Posted for Penectomy
 ,
 ,
Published
May 12, 2023
Abstract
One of the major determinants of the function of the heart is given by the left ventricular ejection fraction. Patients with congestive heart failure have a low ejection fraction and this increases the risk of perioperative adverse cardiac events and sometimes death1. It also changes the plan of anaesthesia along with the outcome. The major goal perioperatively is to maintain hemodynamic stability[1], also maintaining forward flow, promoting inotropy without inducing or exacerbating ischemia and returning patient to their preoperative level of function after surgery[2,3]. In this report we present a 60-year-old male with ischemic heart disease with left ventricular ejection fraction 30% who underwent penectomy under saddle anaesthesia without any complications. We believe that saddle anaesthesia can be a useful alternative anaesthetic technique in patients with low ejection fraction undergoing penectomy for carcinoma of penis. We showed evidence-based and customized anaesthetic management of a high-risk patient with available equipments and resources[1,4].
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
1556 Views
382 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved